Actualités 17 Apr 2024 Addex Therapeutics lance la spin-off Neurosterix à Genève avec un investissement de USD 63 millions La société genevoise Addex Therapeutics s’est associée à Perceptive Advisors pour lancer la spin-off Neurosterix, un nouvel acteur dans le dévelo...
Actualités 30 Apr 2024 Les Grands Titres de Suisse occidentale (Avril 2024) De percées biotechnologiques à la transformation des essais cliniques, en passant par des avancées dans le domaine des matériaux écologiques et d...
News 17 Apr 2024 Addex Therapeutics launches spin-off Neurosterix in Geneva with USD 63 million investment Geneva's Addex Therapeutics has teamed up with Perceptive Advisors to launch spin-off Neurosterix, a new player in neurology-focused drug develop...
News 30 Apr 2024 Top Stories from Western Switzerland (April 2024) From biotech breakthroughs and the transformation of clinical trials to advancements in eco-friendly materials and renewable energy initiatives, ...
News 14 Feb 2024 University of Fribourg discovers drug to combat age-related neuroinflammation Scientists at the University of Fribourg have uncovered a groundbreaking mechanism that could significantly mitigate age-related neuroinflammatio...
News 23 Apr 2024 Swibrace advances to clinical phase with innovative 3D-printed wrist braces Swibrace, in partnership with the Inselspital in Bern, moves its customized wrist braces into clinical phase, enhancing fracture treatment throug...
News 06 Feb 2024 QUMEA secures investment of 9 million Swiss francs QUMEA has raised funding of 9 million Swiss francs as part of an oversubscribed Series A financing round. With this fresh capital, the digital he...
News 04 Dic 2023 Bern University of Applied Sciences launches the Institute for Patient-Centered Digital Health The Bern University of Applied Sciences is set to enhance its foothold in medical informatics with the establishment of a new institute dedicated...
News 20 Mar 2024 Spineart raises CHF 20 million to push the boundaries of spinal surgery Spineart, the Geneva-based pioneer in spinal surgery innovations, has successfully secured over CHF 20 million in convertible financing.
News 10 Gen 2024 The remarkable chemical-pharmaceutical industry in the canton of Valais For decades, the canton of Valais has cultivated a reputation for excellence in the chemical and pharmaceutical industries, combining innovation ...
News 14 Ago 2023 Bern’s thriving ecosystem for life sciences innovation In the heart of Western Switzerland, the canton of Bern has emerged as a location of choice for companies in the life sciences sector.
News 29 Nov 2023 Meditron, EPFL’s new Large Language Model for medical knowledge EPFL researchers have unveiled Meditron, a groundbreaking open-source Large Language Model (LLM) specifically tailored for the medical field.